Not a good buy right now: price just had a sharp breakdown (-17.81% today) and momentum indicators are still deteriorating.
Oversold conditions (RSI_6 ~29) can support a short-term bounce, but without confirmation or a proprietary buy signal, the risk/reward is not attractive for an immediate entry.
Near-term catalyst risk is elevated into earnings (2026-02-12 after hours), especially after commentary around weak FY26 revenue guidance.
Trend/momentum mix: long-term structure looks constructive (SMA_5 > SMA_20 > SMA_200), but short-term momentum is bearish.
MACD histogram (-0.152) is below zero and negatively expanding → selling pressure is strengthening.
RSI_6 at ~29.3 suggests the stock is oversold/near-oversold, which can produce reflex rallies, but does not by itself confirm a bottom.
Key levels: current price (~9.07) is below S1 (9.555), implying a support break; next downside reference is S2 (8.918). Overhead pivot resistance is 10.586, then 11.618.
Pattern-based projection provided: ~70% chance of ~-0.19% next day, +0.84% next week, +4.53% next month—modest upside longer-horizon, but near-term choppy.
Positive Catalysts
(+77.46% YoY), supporting the scaling narrative.
Neutral/Negative Catalysts
Major one-day drawdown (-17.81%) indicates aggressive distribution and weak near-term sentiment/positioning.
MACD deterioration suggests the down-move may not be finished yet.
Prior commentary highlights weak FY26 revenue guidance (Roth), which can continue to pressure the multiple until visibility improves.
No recent news flow in the past week to counter the bearish price action.
No helpful “signal override”: no AI Stock Picker or SwingMax buy signal today.
Financial Performance
Latest quarter: 2025/Q4.
Revenue: $20.506M, up 77.46% YoY (strong top-line momentum).
Gross margin: 28.62%, up 24.27% YoY (improving unit economics).
Net income: $2.048M, reported as down -1896.49% YoY (profitability appears volatile/distorted vs prior year; despite being positive, the YoY change flags instability).
EPS: $0.04, essentially flat YoY per the snapshot.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: ratings are broadly positive, but price targets show dispersion tied to visibility/guidance.
Raymond James (2025-12-11): Strong Buy, PT raised to $9.50 (constructive on material handling demand and new verticals).
Roth Capital (2025-12-11): Buy, PT cut to $7 (cites weak FY26 revenue guidance; wants better growth visibility).
Wall Street pros/cons view: Pros—technology/IP + strong end-market adoption theme + revenue growth; Cons—guidance/visibility concerns and current sharp technical damage.
Wall Street analysts forecast ELVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELVA is 9.9 USD with a low forecast of 7 USD and a high forecast of 14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast ELVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELVA is 9.9 USD with a low forecast of 7 USD and a high forecast of 14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 8.160
Low
7
Averages
9.9
High
14
Current: 8.160
Low
7
Averages
9.9
High
14
Oppenheimer
Outperform
initiated
$14
AI Analysis
2025-12-18
Reason
Oppenheimer
Price Target
$14
AI Analysis
2025-12-18
initiated
Outperform
Reason
Oppenheimer initiated coverage of Electrovaya with an Outperform rating and $14 price target. The firm says Electrovaya is a leading battery technology platform with "defensible" intellectual property in materials design, manufacturing, and handling. The company is well positioned to scale through the material handling market and become a critical enabler of autonomous mobile robot performance, the analyst tells investors in a research note.
Roth Capital
Buy
downgrade
$10 -> $7
2025-12-11
Reason
Roth Capital
Price Target
$10 -> $7
2025-12-11
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Electrovaya to $7 from $10 and keeps a Buy rating on the shares. The company reported Q4 results essentially in-line with consensus and issued weak FY26 revenue guidance, the analyst tells investors in a research note. Roth adds it would prefer to see an improved growth visibility, which may come from new products, before becoming opportunistic on the stock.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ELVA
